NATURES SUNSHINE PRODUCTS INC
NATR evidence brief
What we can confirm
- BioSniper Score:
- 7.3 / 10
- Market Cap:
- $229.1M
What it means
What to watch
Prepared research question
What matters most for NATR—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper AI · NATR
Natures Sunshine Products Inc (NATR) is a direct-selling nutritional supplements company that reported $117.0M in total revenue and $3.5M in net income for the period ending June 30, 2026, with $82.5M in cash and equivalents.
Key risk: No recent catalysts
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$229.1M
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Jun 30, 2026.
Tracking 3 clinical trials for NATURES SUNSHINE PRODUCTS INC.
Natures Sunshine Products Inc (NATR) is a direct-selling nutritional supplements company that reported $117.0M in total revenue and $3.5M in net income for the period ending June 30, 2026, with $82.5M in cash and equivalents.
- Cash and equivalents of $82.5M as of 2026-06-30 [sec]
- Total revenue of $117.0M as of 2026-06-30 [sec]
- Net income of $3.5M as of 2026-06-30 [sec]
What works
- Strong cash position of $82.5M provides financial flexibility for operations and potential investments [sec]
- Positive net income of $3.5M indicates the company is currently profitable [sec]
What to weigh
- No recent clinical or regulatory catalysts were identified in the provided data, which may limit near-term growth visibility [competitor_trial]
- The company operates in a competitive nutritional supplements market where many competitors are pursuing advanced metabolic drug trials, potentially drawing consumer and investor attention away [competitor_trial]
Risks & what to watch (2)›
Key risks
- No recent catalysts — No upcoming catalysts or recent clinical/regulatory milestones were found in the provided data, which may indicate a quiet pipeline [competitor_trial]
- Competitive pressure — Multiple large competitors are conducting advanced metabolic trials, potentially shifting market focus away from supplements [competitor_trial]
What to watch
- Future financial filings for revenue and net income trends [sec]
- Any new product launches or regulatory approvals in the nutritional supplements space [competitor_trial]
Sources: Competitor trials · Generated October 4, 2026 · How we verify sources →
Run NATURES SUNSHINE PRODUCTS INC through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available NATURES SUNSHINE PRODUCTS INC facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Evidence & data
Score breakdownBased on 2 of 6 signals · derived from public data
Pipeline inputs are unavailable for this score. It uses only the available signals shown below.
Cash runway data unavailable
Net income $4M
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
14 buys · 5 sells (180d)
Regulatory
Financials
Short Interest
as of May 13, 2026- % of float
- 2.1%
- Days to cover
- 3.4
- Shares short
- 269,513
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
NATR short interestGovernance
Frequently asked questions
What is the AI investment thesis for NATURES SUNSHINE PRODUCTS INC?
Natures Sunshine Products Inc (NATR) is a direct-selling nutritional supplements company that reported $117.0M in total revenue and $3.5M in net income for the period ending June 30, 2026, with $82.5M in cash and equivalents.
Who is the CEO of NATURES SUNSHINE PRODUCTS INC?
Mr. Kenneth G. Romanzi is the chief executive officer of NATURES SUNSHINE PRODUCTS INC (NATR).
Where is NATURES SUNSHINE PRODUCTS INC headquartered?
NATURES SUNSHINE PRODUCTS INC (NATR) is headquartered in Lehi, UT, United States.
What therapeutic areas does NATURES SUNSHINE PRODUCTS INC focus on?
NATURES SUNSHINE PRODUCTS INC develops therapies across Metabolic.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.